Using bioabsorbable staples to improve surgery outcomes for rectal and lung cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a bioabsorbable staple line reinforcement material in comparison to standard stapling techniques during stomach, colorectal, and lung surgeries. It is a randomized, prospective multicenter study aimed at reducing postoperative complications such as hemorrhage and anastomotic leakage. Participants will be monitored for outcomes related to these complications following their surgeries. The study seeks to determine if the new reinforcement material can provide better surgical results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects who will undergo operation with stapled stomach, colorectal anastomosis with or without reinforcement
* Subjects willing to accept informed consent and willing to attend the follow up

Exclusion Criteria:

* Subjects who have significant intraoperative hypotension or cardiac events.
* Subjects with collagen vascular disease, coagulopathy, significant renal or hepatic dysfunction (creatinine \>1.6 or liver enzymes \> 50% upper limit of normal values).
* Subjects have uncontrolled intra-abdominal infection

Where it's running

• Renji hospital affiliated to Shanghai jiaotong Uni school of medicine
  Shanghai, China Recruiting

Study contacts

• Study coordinator: study director
• Email: july_s@126.com
• Phone: 02138016387

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Neoadjuvant mFOLFOX with Citrus Flavonoid Tablets for YWHAB-High Locally Advanced Rectal Cancer

  In people with locally advanced rectal cancer who have high YWHAB expression, this study tests whether adding citrus flavonoid tablets to a standard mFOLFOX neoadjuvant regimen helps shrink tumors before surgery.

  Recruiting Phase 2 Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07176182

• Meal timing during cancer treatment for Alaska Native and American Indian patients

  This test will see if an 8-hour time-restricted eating schedule during neoadjuvant or adjuvant therapy helps Alaska Native and American Indian adults with rectal or certain breast cancers.

  Recruiting Fred Hutchinson Cancer Center · Anchorage, Alaska · NCT06802172

• Monitoring blood markers to predict treatment response in rectal cancer

  This study is testing if measuring certain blood markers in patients with stage II and III rectal cancer can help predict how well they respond to treatment.

  Recruiting Gene Solutions · Ho Chi Minh City · NCT06589388

• Prehabilitation program for patients with rectal cancer

  This study is testing a prehabilitation program to see if it helps people with rectal cancer feel better before surgery compared to standard care.

  Recruiting at 2 sites Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT06565052

• Targeted therapy for patients with unresectable stage III lung cancer and rare mutations

  This study is testing if targeted therapies for rare mutations can help patients with advanced lung cancer who can't have surgery and haven't been treated before.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT06563999

• Effects of Tislelizumab with Chemotherapy in Advanced Rectal Cancer

  This study is testing if adding a new drug called Tislelizumab to chemotherapy can help people with advanced rectal cancer have better outcomes before surgery.

  Recruiting Phase 2 First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi · NCT06254521

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.